Nav: Home

Vigorous exercise reduces tiredness in testicular cancer survivors

May 07, 2018

High intensity interval training reduces tiredness and improves self-esteem for testicular cancer survivors, according to a study published in the British Journal of Cancer today (Tuesday)*.

It found that men who had been treated for testicular cancer and had the lowest fitness levels benefited the most from this strenuous exercise regime.

Researchers invited 63 testicular cancer survivors to take part in a 12-week exercise programme which included repeatedly walking fast uphill on a treadmill set at an incline for two minutes and then at a slower pace on the flat for the same length of time.

The men reported significant improvements in energy levels and self-esteem compared to those who just received their usual follow up care. They also felt less tired and had more vitality three months later.

In the UK around 2,300 men are diagnosed with testicular cancer each year and it is most common in those in their early 30s.** Patients are likely to experience treatment-related fatigue.

Study senior author Professor Kerry S Courneya based at the University of Alberta in Canada, said: "This small study shows the men who had the biggest increase in fitness saw the greatest benefits. This indicates higher intensity exercise, which increases fitness levels, has more impact than more moderate activity.

"What's so exciting is that this programme would be easy to introduce to patients as it's as simple as jogging for two minutes and walking for two minutes. It can also be specifically targeted at men who aren't fit and suffer with tiredness."

Martin Ledwick, Cancer Research UK head information nurse said: "This adds to the increasing evidence that exercise programmes can improve wellbeing and fatigue after cancer treatment.

"Tiredness can be really debilitating for patients so it is great that simple and specific ways to help combat this are being explored."
-end-
Notes to editor:

*Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors, Scott C Adams, Darren S DeLorey, Margie H Davenport, Adrian S Fairey, Scott North, Kerry S Courneya, British Journal of Cancer (2018) 10.1038/s41416-018-0044-7

Post embargo link: http://www.nature.com/articles/s41416-018-0044-7

**http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/testicular-cancer#heading-Zero

About the British Journal of Cancer (BJC)

The BJC is owned by Cancer Research UK. Its mission is to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made BJC one of the world's premier general cancer journals. http://www.bjcancer.com

Cancer Research UK

Related Testicular Cancer Articles:

Chlamydia in testicular tissue linked to male infertility
The potential impact of undiagnosed sexually transmitted chlamydia infection on men's fertility has been highlighted in a study led by scientists at Queensland University of Technology (QUT), which for the first time found chlamydia in the testicular tissue biopsies of infertile men whose infertility had no identified cause.
Scientists discover autoimmune disease associated with testicular cancer
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
No increased risk of birth defects in children of fathers treated for testicular cancer
New research has found no increased risk of congenital malformations associated with treatment with radiotherapy or chemotherapy in children of fathers with testicular cancer.
Sperm quality unaffected by one course of chemotherapy for early testicular cancer
Men with early stage testicular cancer can safely receive one course of chemotherapy or radiotherapy after surgery without it having a long-term effect on their sperm count, according to a study published in Annals of Oncology.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
More Testicular Cancer News and Testicular Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...